DIDO1 and Hepatic fibrosis: Previous studies have indicated that EV circ-death inducer-obliterator 1 (circ-DIDO1) is positively correlated with liver fibrosis because of its ability to suppress HSC activation via the miR-141-3p/PTEN/AKT pathway [101].